11 publications
9 publications
6 publications
4 publications
4 publications
4 publications
4 publications
3 publications
3 publications
3 publications
2 publications
2 publications
2 publications
2 publications
1 publication
1 publication
1 publication
1 publication
1 publication
1 publication
1 publication
1 publication
1 publication
1 publication
1 publication
1 publication
1 publication
1 publication
BCTRIMS 2024
Discontinuation of Disease Modifying Drugs in Older Multiple Sclerosis Patients with Stable Disease: A Retrospective Observational Study
BCTRIMS 2024
The long Journey to achieve high efficacy therapy – Alemtuzumab in Brazilian public scenario
BCTRIMS 2024
Cytokine Storms during Alemtuzumab Infusion: A case series
BCTRIMS 2024
Profile of infusion-associated reactions with Alemtuzumab in a Brazilian reference center.
BCTRIMS 2024
Unveiling the Silent Threat: Exploring Latent Tuberculosis in Multiple Sclerosis Patients Undergoing Novel Therapies
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper